Session Details

Drug design 1

Fri. Mar 29, 2024 1:15 PM - 2:15 PM JST
Fri. Mar 29, 2024 4:15 AM - 5:15 AM UTC
[Room 413] Conference Center 413 (4F)
Chair: Baba Yoshiyasu, Tetsuta Oshitari

[29-413-pm01S]Effect of modification pattern of gapmer antisense oligonucleotides on off-target toxicity

○Chihiro Oda1,2, Yuuya Kasahara1,2, Harumi Yamaguma2, Satoshi Obika1,3 (1. Grad. Sch. Pharm. Sci., Osaka Univ., 2. NIBIOHN, 3. OTRI, Osaka Univ.)

[29-413-pm02]Design of antisense oligonucleotides targeting a host factor for antiviral drug development

○Yuuya Kasahara1, Tokiko Watanabe2,3,4, Natsumi Kameoka1, Harumi Yamaguma1, Itsuki Anzai2,3, Hina Miyazaki2, Kosuke Takada2, Yurie Kida2, Satoshi Obika3,4,5,6 (1. NIBIOHN, 2. RIMD, Osaka Univ., 3. CiDER, 4. CAMaD, 5. Grad. Sch. Pharm. Sci., Osaka Univ., 6. OTRI, Osaka Univ.)

[29-413-pm03S]Structure-activity relationship (SAR) study of hydrophobic moiety of nonsecosteroidal VDR ligands using diphenylsilane scaffold

○Hansaka Nirupama Thilakarathne Narasinghe Mudiyanselage1,2, Takashi Misawa3, Yosuke Demizu3, Yuya Hanazono2, Nobutoshi Ito2, Hiroyuki Kagechika1, Shinya Fujii1 (1. Institute of Biomaterials and Bioengineering, Tokyo medical and Dental University, 2. Medical Research Institute, Tokyo Medical and Dental University, 3. National Institute of Health Sciences)

[29-413-pm04S]Physicochemical property and estrogenic activity of B-(hydroxyphenyl) phosphine borane derivatives

○Yu Miyajima1, Tomomi Noguchi-Yachide2, Hiroyuki Kagechika1, Shinya Fujii1 (1. IBB, Tokyo Medical and Dental Univ., 2. IQB, The Univ. of Tokyo)

[29-413-pm05S]Development of novel XIAP inhibitors by using peptidomimetics

○Koutaro Sasaki1, Ruka Ito2, Yuria Kuwana2, Kouji Kuramochi3, Atsushi Yoshimori4, Ryoko Takasawa1,2 (1. Dept. Pharm. Sci., Grad. Sch. Pharm. Sci., Tokyo Univ. Sci., 2. Facul. Pharm. Sci., Tokyo Univ. Sci., 3. Facul. Sci. Tech., Tokyo Univ. Sci., 4. ITM, Inc.)